GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » Price-to-Operating-Cash-Flow

Mauna Kea Technologies (Mauna Kea Technologies) Price-to-Operating-Cash-Flow : 74.00 (As of May. 03, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies Price-to-Operating-Cash-Flow?

As of today (2024-05-03), Mauna Kea Technologies's share price is $0.37. Mauna Kea Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Hence, Mauna Kea Technologies's Price-to-Operating-Cash-Flow Ratio for today is 74.00.

The historical rank and industry rank for Mauna Kea Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

MKEAF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 140
Current: 97.5

During the past 13 years, Mauna Kea Technologies's highest Price-to-Operating-Cash-Flow Ratio was 140.00. The lowest was 0.00. And the median was 0.00.

MKEAF's Price-to-Operating-Cash-Flow is ranked worse than
92.52% of 441 companies
in the Medical Devices & Instruments industry
Industry Median: 21.67 vs MKEAF: 97.50

Mauna Kea Technologies's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.70% per year.

During the past 13 years, Mauna Kea Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.20% per year. The lowest was -15.90% per year. And the median was 16.90% per year.


Mauna Kea Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Mauna Kea Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Price-to-Operating-Cash-Flow Chart

Mauna Kea Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mauna Kea Technologies Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mauna Kea Technologies's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Mauna Kea Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mauna Kea Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Price-to-Operating-Cash-Flow falls into.



Mauna Kea Technologies Price-to-Operating-Cash-Flow Calculation

Mauna Kea Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.37/0.005
=74.00

Mauna Kea Technologies's Share Price of today is $0.37.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mauna Kea Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Mauna Kea Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines